Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
abstracts [2020/07/28 13:14] – RRS2020 ptsp5h | abstracts [2021/04/15 15:15] – [Improving the Technique of a Heterotopic Vascularized Composite Hindlimb Allotransplantation in the Pig] ptsp5h | ||
---|---|---|---|
Line 2: | Line 2: | ||
*My* submitted abstracts are archived here or reside on this page until they have been either shown as [[posters|a poster]] or I have given [[talks|the talk]]. | *My* submitted abstracts are archived here or reside on this page until they have been either shown as [[posters|a poster]] or I have given [[talks|the talk]]. | ||
Abstracts where I've been part of the team or have not been presented in the end remain listed here for book-keeping reasons. | Abstracts where I've been part of the team or have not been presented in the end remain listed here for book-keeping reasons. | ||
+ | |||
+ | ====== Repression of wilm’s tumor protein 1 is required to promote myocardial fate ====== | ||
+ | * Ines J. Marques, Alexander Ernst, Tanja Hetke, Prateek Arora, Andres Sanz, Javier Langa, Adolfo Odriozola, Benôit Zuber, David Haberthür, Ruslan Hlushchuk, Carlos Torroja, Uta Naumann, Christoph Englert, Nadia Mercader | ||
+ | * [[https:// | ||
+ | |||
+ | ====== Improving the Technique of a Heterotopic Vascularized Composite Hindlimb | ||
+ | * Stefanie Hirsiger, Ioana Lese, Isabel Arenas Hoyos, Nicoletta Sorvillo, Cedric Zubler, David Haberthür, Ruslan Hlushchuk, Yara Banz, Ana Leban, Hendrik von Tengg-Kobligk, | ||
+ | * [[https:// | ||
====== The first pre-clinical study employing Synchrotron Microbeam Radiotherapy for the treatmend of lung carcinoma ====== | ====== The first pre-clinical study employing Synchrotron Microbeam Radiotherapy for the treatmend of lung carcinoma ====== |